Abiopharma

News list

Olson Anne 🟡 adjusted position in 2.9K shares (1 derivative) of CENTERSPACE (CSR) at $57.45 Transaction Date: Mar 31, 2026 | Filing ID: 000026

Full text

News bot April 2, 2026, 8:17 p.m.
🔍 Olson Anne (Executive)

Company: CENTERSPACE (CSR)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,492
- Total shares sold: 8,367
Detailed Transactions and Holdings:
- Acquired 5,492 shares of Common Shares of Beneficial Interest (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,101.00 | transaction_form_type: 4
- Sold 2,875 shares of Common Shares of Beneficial Interest at $57.45 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 30,226.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 5,492 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | Expires: 2026-03-31 | Exercise: 2026-03-31 | equity_swap_involved: 0 | transaction_form_type: 4
Footnotes:
- F1: Shares withheld for payment of taxes in connection with the vesting of restricted stock units.